Journal Article

Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-<i>db</i>/<i>db</i> mice

Yoshinobu Hirose, Kazuya Hata, Toshiya Kuno, Koujiro Yoshida, Keiko Sakata, Yasuhiro Yamada, Takuji Tanaka, Bandaru S. Reddy and Hideki Mori

in Carcinogenesis

Volume 25, issue 5, pages 821-825
Published in print May 2004 | ISSN: 0143-3334
Published online May 2004 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgh059
Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Epidemiological studies have shown that obesity and diabetes mellitus may be risk factors for colon cancer. However, the underlying mechanisms of how these chronic diseases promote colon carcinogenesis remain unknown. C57BL/KsJ-db/db mice have obese and diabetic phenotypes because of disruption of the leptin receptor. The present study was designed to investigate whether development of azoxymethane (AOM)-induced dysplastic and early neoplastic (premalignant) lesions of the colon is modulated in db/db mice. Homozygous db/db mice, heterozygous db/+ mice and littermate controls (+/+) were injected with AOM under food restriction (∼10.8 kcal/mouse/day) and killed 5 weeks after the carcinogen treatment. Their colons were assessed for premalignant lesions induced by AOM. We found a significant increase in the multiplicity of the total premalignant lesions in db/db mice when compared with db/+ or +/+ mice. Phenotypically, serum leptin and insulin levels in db/db mice were significantly higher than those in db/+ or +/+ mice, whereas the body weights and glucose levels in blood of db/db, db/+ and +/+ mice were comparable. In addition, immunostaining of the leptin receptor and insulin-like growth factor-I receptor showed up-regulation of these protein levels specifically in the lesions. Our data indicate that development of AOM-induced premalignant lesions is enhanced in db/db mice with hyperleptinemia and hyperinsulinemia. The results have important implications for further exploration of the possible underlying events that affect the positive association between colon cancer and chronic diseases (obesity and diabetes).

Keywords: ACF, aberrant crypt foci; AOM, azoxymethane; EIA, enzyme immunoassay; H&E, hematoxylin and eosin; IGF-I, insulin-like growth factor-I; IGF-IR, insulin-like growth factor-I receptor; MAPK, mitogen-activated protein kinase; Ob-R, leptin receptor

Journal Article.  3547 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.